Symbotic Raises $358M via Discounted Share Sale as SoftBank Sells 3.5M Shares
Symbotic raised $358 million through a 10 million share offering priced at $55 on Dec. 3, a 25% discount to trading levels that diluted shareholders as SoftBank sold 3.5 million shares. Management forecasts 27% revenue growth next quarter and secured its first healthcare client, diversifying beyond Walmart exposure.
1. Significant December Share Sell-Off Triggers 29% Decline
Symbotic shares fell 29% over the course of December after management and a major investor executed a large equity offering. The sell-off wiped out much of the stock’s year-to-date gains—despite a 150% advance earlier in the year—and reflected investor concern over dilution rather than underlying business performance.
2. Details of the Equity Offering and Capital Raise
On December 3, Symbotic sold 10 million new shares, raising approximately $358 million. Of that, 6.5 million shares were issued by the company for general corporate purposes; the remaining 3.5 million shares were sold by SoftBank, which retained all proceeds. SoftBank’s block represented less than 10% of its roughly 40 million-share stake as of September 30, underscoring that this transaction was a liquidity event rather than a full exit.
3. Strong Fundamentals and Growth Outlook Remain Intact
Symbotic ended the September quarter with nearly $1.25 billion in cash and equivalents and generated positive free cash flow across the fiscal year. Management projects 27% revenue growth at the midpoint for the upcoming quarter, up from 26% year-over-year growth in the last fiscal year. The company also secured its first healthcare client, diversifying beyond its core e-commerce warehouse automation market, where one customer accounted for about 85% of sales last year.